AstraZeneca plc (AZN) Welcomes European Green Light For Its Coronavirus Vaccine
Coronavirus vaccine developed by AstraZeneca plc (NASDAQ: AZN) and Oxford University have been approved by the European Medicines Agency for people aged 18 and over. Particularly, the European Medicines Agency (EMA) suggests that the AstraZeneca vaccine against coronavirus has been evaluated as safe and effective, and unanimously recommends its conditional approval by the European Commission. […]